Genetic Modification of T Cells with Chimeric Antigen Receptors: A Laboratory Manual-Reference-Cited by-同舟云学术

Genetic Modification of T Cells with Chimeric Antigen Receptors: A Laboratory Manual

Published:2017-12 Issue:6 Volume:28 Page:302-309
ISSN:1946-6536
Container-title:Human Gene Therapy Methods
language:en
Short-container-title:Human Gene Therapy Methods

Author:

Golumba-Nagy Viktória¹,Kuehle Johannes¹,Abken Hinrich¹

Affiliation:

1. Center for Molecular Medicine Cologne, University of Cologne, and Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Genetics (clinical),Pharmacology,Genetics,Applied Microbiology and Biotechnology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hgtb.2017.083

Reference33 articles.

1. The growing world of CAR T cell trials: a systematic review

2. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

3. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.

4. Tumor-Specific T Cell Activation by Recombinant Immunoreceptors: CD3ζ Signaling and CD28 Costimulation Are Simultaneously Required for Efficient IL-2 Secretion and Can Be Integrated Into One Combined CD28/CD3ζ Signaling Receptor Molecule

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetic CAR T cell purification using an anti-G4S linker antibody;Journal of Immunological Methods;2024-05

2. Pitfalls in patenting academic CAR-T cells therapy;Expert Opinion on Therapeutic Patents;2023-05-04

3. CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation;Frontiers in Immunology;2023-02-01

4. A CD19-Anti-ErbB2 scFv Engager Protein Enables CD19-Specific CAR T Cells to Eradicate ErbB2+ Solid Cancer;Cells;2023-01-07

5. CAR Triggered Release of Type-1 Interferon Limits CAR T-Cell Activities by an Artificial Negative Autocrine Loop;Cells;2022-11-30